Manuel Gutiérrez de Ravé: My Personal Takeaways from 39th International ISBT Annual Congress
Manuel Gutiérrez de Ravé, Real-World Evidence (RWE) Scientist at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“The 39th International ISBT Annual Congress once again proved to be an unparalleled forum for scientific dissemination and educational training, fostering collaboration among the diverse stakeholders of the transfusion medicine community.
Here are my personal takeaways of this year:
Donor Management: following recurrent quality-monitoring failures and blood product discards is important to assess potential underlying conditions that may affect donor health.
Hemovigilance:. A fully interconnected ecosystem is essential to ensure vein-to-vein safety, with traceability serving as the foundation rather than merely a compliance exercise.
Multi-omic insights into blood products during storage, together with donor variability, will help shape blood banking and personalised medicine and improve transfusion effectiveness.
PBM in Surgical settings has consistently shown that restrictive transfusion strategies provide equal or superior clinical benefits compared with liberal strategies.
New blood products: ABO universal blood, achieved through enzymatic conversion to group O, and synthetic oxygen carriers may become important additions to blood supply inventories in crisis settings and remote areas in the coming years.
Artificial intelligence: Semantic search, clustering, and Retrieval-Augmented Generation (RAG) can be combined to create more accurate, context-aware, and scalable generative AI systems, drastically reducing the risk of AI hallucinations.
Finally, I was thrilled to meet many TBCT colleagues from other regions in person, exchange ideas, build new relationships, and collaborate to pursue excellence in blood technologies.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 05:4710-Minute Paper-Strip Test Detects Factor VIII Inhibitors in Resource-Limited Settings – JTH
-
Jun 27, 2026, 05:23New episode – From Groundbreaking Therapies to the Ongoing Fight for Diagnosis – Global Hemophilia Report
-
Jun 27, 2026, 05:08Bethany Brown: Over 400 Ground EMS Agencies Now Carry Lifesaving Blood
-
Jun 27, 2026, 04:56Reza Shojaei: The Plasma Risk Governments Are Ignoring
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management